Testing effectiveness (Phase 2)Looking for participantsNCT06444399What this trial is testingDeucravacitinib (BMS-986165) for Pityriasis Rubra PilarisWho this might be right forPityriasis Rubra Pilaris Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT03485976What this trial is testingIxekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)Who this might be right forPityriasis Rubra Pilaris Oregon Health and Science University 12
Post-approval studies (Phase 4)Ended earlyNCT00815633What this trial is testingA Pilot Study of Alefacept for the Treatment of Pityriasis Rubra PilarisWho this might be right forPityriasis Rubra Pilaris Joshua Zeichner 1
Testing effectiveness (Phase 2)Study completedNCT03975153What this trial is testingGuselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)Who this might be right forPityriasis Rubra Pilaris Oregon Health and Science University 15
Early research (Phase 1)Study completedNCT03342573What this trial is testingCosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra PilarisWho this might be right forPITYRIASIS RUBRA PILARIS Mayo Clinic 12